| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |